Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Averica Discovery Systems
Averica Discovery Systems
Activities:
Research & Development
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Ingredients
Averica expands pharmaceutical impurities services
Averica Discovery Services has expanded its service to include services such as nitrosamine and PFAS testing
Research & Development
Canadian-based Neopharm Labs completes acquisition of Boston-based Averica Discovery Services
The combined expertise creates a key player in the North American analytical market
Research & Development
Averica Discovery appoints Cynthia Berger as Vice President of Operations
Will contribute broadly to the firm's growth and development
Regulatory
Averica now able to handle Schedule I controlled substances
And expand the types of research that the company can support
Subscribe now